Boehringer Ingelheim Breaks Ground on $217 Million Expansion of Fremont, California Manufacturing Facility Read more
Pfizer Completes License Agreement For The Exclusive Commercialization Rights In Europe For CRESEMBA (isavuconazole) Read more